Cellectar Biosciences (CLRB) Misses Q1 EPS by 21c

Cellectar Biosciences (NASDAQ: CLRB) reported Q1 EPS of ($0.74), $0.21 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Cellectar Biosciences (CLRB) click here.

You May Also Be Interested In

• Cellectar Biosciences (CLRB) Misses Q2 EPS by 9c
• Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance
• Pelthos Therapeutics Inc. (PTHS) Misses Q2 EPS by 611c